IBM Study: Consumers' COVID-19 outlook, optimism and preferences vary greatly across generations and geographies

ARMONK, N.Y., Sept. 2, 2020 /PRNewswire/ — The August findings of an ongoing IBM (NYSE: IBM) Institute for Business Value (IBV) survey of global consumers reveal that across the globe individuals remain highly concerned about the impact of the COVID-19 pandemic on their daily lives, but there are clear differences in outlook across age groups and countries. The survey of more than 14,500 adults across Brazil, China, Germany, India, Mexico, Spain, the United Kingdom and the United States showed that due to the pandemic individuals are making marked changes in how they work, shop and live – new habits that may not shift dramatically even once a vaccine becomes available. “Our data tells us that many individuals are looking for more transparency and flexibility from their employers as they navigate this great uncertainty caused by the pandemic,” said Jesus Mantas, senior managing partner, IBM Services. “Organizations need to focus on building trust with their workforce and customers, and agility to deliver solutions that meet them where they are.” Global optimism remains stagnant with concerns divided among generations and countries Consumers globally report high levels of concern about the pandemic and its impact on their lives. The overwhelming majority of global respondents said they believe we will see more pandemic events like this in the future. 69% of Americans surveyed expressed concern about a second wave hitting later in 2020, while in the UK, Mexico, Spain and Brazil, at least three in four respondents expressed similar views. 70% of surveyed Americans said COVID-19 has made them more concerned about the safety and health of themselves and their families, consistent with July. 88% of Brazilians and 54% of Germans surveyed agreed. There is consumer optimism, however, with one-third of responding Americans who believe the U.S. economy will recover in 2021. Compared to other countries, respondents in India and China were the most optimistic about their national economies recovering in 2020.   Globally, the data suggests there is a generation gap. Consumers’ opinions about the impact of the pandemic vary widely across age groups: 69% of millennials (ages 25-39) are concerned about their job security and 60% said the pandemic has taken a toll on their mental health, higher than all other age groups. Baby Boomers (ages 55-70+) are the most pessimistic on economic recovery, with seven in ten reporting they believe their nation’s economy will continue to see an economic downturn or significant recession. Generation Z (ages 18-24) is the most optimistic about the economy, with more than half noting they believe the economy will recover to its pre-COVID-19 state in the next few months. Many employees have high expectations for transparency and flexibility from their employers In the midst of the COVID-19 pandemic, more than half (52%) of Americans surveyed reported that they trust their employer. At the same time, their expectations about the measures needed to feel comfortable returning to a workplace remained high across August and July. 64% of Americans surveyed said employers need to clearly communicate what is being done to sanitize the workplace (63% in July), and more than half indicated interest in technology-driven solutions like systems for reserving spaces to avoid crowded ‘hot spots’ in the workplace. Some participating consumers seem to be feeling the fatigue of “working from home” feeling more like “living at work.” The percentage of responding Americans indicating they would like to continue to work remotely at least occasionally declined from more than 80% in July to 67% in August, and half said they wanted remote work to be their primary way of working (down 15 points from July). India had the highest percentage (33%) of respondents preferring to exclusively work remotely. Roughly one in three Americans surveyed cited mental health as the number one factor affecting their preference for their future working environment; nearly half of respondents in India and Brazil agreed. Other U.S. findings among those surveyed: Skills: Nearly one in three Americans report taking more online training or education as a result of COVID-19. Back to school: More than half of Americans are worried that sending students back in person will lead to further outbreaks. At the same time, four in ten are concerned that their child(ren) will fall behind in their education if schools do not reopen this year. 47% of feel strongly that their employer should provide special accommodations for childcare needs (41% in July). New patterns for shopping and visiting venues in the U.S. reveal opportunities for businesses to provide options that meet consumers where they are During the pandemic, American consumers have been experimenting with new types of shopping services and tools – even across the technological generation gap. 44% of those surveyed have tried or would like to try placing an order via mobile app (30% pre-pandemic), 46% ordering online with curbside pickup (18% pre-pandemic), and 30% virtually trying on an outfit (9% pre-pandemic). But almost seven in ten Americans surveyed believe a COVID-19 vaccine will not be available until 2021 or later, and even when a vaccine is available, many consumers are not sure if they will be comfortable visiting many types of venues. Only 27% will definitely visit a shopping mall once a vaccine is available, 21% a movie theater and 18% a live sporting event. The IBV has surveyed more than 68,000 consumers since April and plans to continue polling the public in the months ahead. Later this fall, the IBV plans to release a report examining how more than 3,500 C-Suite executives globally are transforming their business to survive and thrive in the new normal across industries such as banking, retail, healthcare and technology. About IBM Institute for Business Value The IBM Institute for Business Value (IBV) delivers trusted business insights from our position at the intersection of technology and business, combining expertise from industry thinkers, leading academics, and subject matter experts with global research and performance data. The IBV thought leadership portfolio includes research deep dives, benchmarking and performance comparisons, and data visualizations that support business decision making across regions, industries and technologies. Follow @IBMIBV on Twitter, and to receive the latest insights by email, visit: www.ibm.com/ibv. Media ContactLeslie Parkleslie.park@ibm.com 201-230-1418 SOURCE IBM

ARMONK, N.Y., Sept. 2, 2020 /PRNewswire/ — The August findings of an ongoing IBM (NYSE: IBMInstitute for Business Value (IBV) survey of global consumers reveal that across the globe individuals remain highly concerned about the impact of the COVID-19 pandemic on their daily lives, but there are clear differences in outlook across age groups and countries.

The survey of more than 14,500 adults across Brazil, China, Germany, India, Mexico, Spain, the United Kingdom and the United States showed that due to the pandemic individuals are making marked changes in how they work, shop and live – new habits that may not shift dramatically even once a vaccine becomes available.

“Our data tells us that many individuals are looking for more transparency and flexibility from their employers as they navigate this great uncertainty caused by the pandemic,” said Jesus Mantas, senior managing partner, IBM Services. “Organizations need to focus on building trust with their workforce and customers, and agility to deliver solutions that meet them where they are.”

Global optimism remains stagnant with concerns divided among generations and countries

Consumers globally report high levels of concern about the pandemic and its impact on their lives. The overwhelming majority of global respondents said they believe we will see more pandemic events like this in the future. 69% of Americans surveyed expressed concern about a second wave hitting later in 2020, while in the UK, Mexico, Spain and Brazil, at least three in four respondents expressed similar views.

70% of surveyed Americans said COVID-19 has made them more concerned about the safety and health of themselves and their families, consistent with July. 88% of Brazilians and 54% of Germans surveyed agreed.

There is consumer optimism, however, with one-third of responding Americans who believe the U.S. economy will recover in 2021. Compared to other countries, respondents in India and China were the most optimistic about their national economies recovering in 2020.  

Globally, the data suggests there is a generation gap. Consumers’ opinions about the impact of the pandemic vary widely across age groups:

  • 69% of millennials (ages 25-39) are concerned about their job security and 60% said the pandemic has taken a toll on their mental health, higher than all other age groups.
  • Baby Boomers (ages 55-70+) are the most pessimistic on economic recovery, with seven in ten reporting they believe their nation’s economy will continue to see an economic downturn or significant recession.
  • Generation Z (ages 18-24) is the most optimistic about the economy, with more than half noting they believe the economy will recover to its pre-COVID-19 state in the next few months.

Many employees have high expectations for transparency and flexibility from their employers

In the midst of the COVID-19 pandemic, more than half (52%) of Americans surveyed reported that they trust their employer. At the same time, their expectations about the measures needed to feel comfortable returning to a workplace remained high across August and July. 64% of Americans surveyed said employers need to clearly communicate what is being done to sanitize the workplace (63% in July), and more than half indicated interest in technology-driven solutions like systems for reserving spaces to avoid crowded ‘hot spots’ in the workplace.

Some participating consumers seem to be feeling the fatigue of “working from home” feeling more like “living at work.” The percentage of responding Americans indicating they would like to continue to work remotely at least occasionally declined from more than 80% in July to 67% in August, and half said they wanted remote work to be their primary way of working (down 15 points from July). India had the highest percentage (33%) of respondents preferring to exclusively work remotely.

Roughly one in three Americans surveyed cited mental health as the number one factor affecting their preference for their future working environment; nearly half of respondents in India and Brazil agreed.

Other U.S. findings among those surveyed:

  • Skills: Nearly one in three Americans report taking more online training or education as a result of COVID-19.
  • Back to school: More than half of Americans are worried that sending students back in person will lead to further outbreaks. At the same time, four in ten are concerned that their child(ren) will fall behind in their education if schools do not reopen this year. 47% of feel strongly that their employer should provide special accommodations for childcare needs (41% in July).

New patterns for shopping and visiting venues in the U.S. reveal opportunities for businesses to provide options that meet consumers where they are

During the pandemic, American consumers have been experimenting with new types of shopping services and tools – even across the technological generation gap. 44% of those surveyed have tried or would like to try placing an order via mobile app (30% pre-pandemic), 46% ordering online with curbside pickup (18% pre-pandemic), and 30% virtually trying on an outfit (9% pre-pandemic).

But almost seven in ten Americans surveyed believe a COVID-19 vaccine will not be available until 2021 or later, and even when a vaccine is available, many consumers are not sure if they will be comfortable visiting many types of venues. Only 27% will definitely visit a shopping mall once a vaccine is available, 21% a movie theater and 18% a live sporting event.

The IBV has surveyed more than 68,000 consumers since April and plans to continue polling the public in the months ahead. Later this fall, the IBV plans to release a report examining how more than 3,500 C-Suite executives globally are transforming their business to survive and thrive in the new normal across industries such as banking, retail, healthcare and technology.

About IBM Institute for Business Value 
The IBM Institute for Business Value (IBV) delivers trusted business insights from our position at the intersection of technology and business, combining expertise from industry thinkers, leading academics, and subject matter experts with global research and performance data. The IBV thought leadership portfolio includes research deep dives, benchmarking and performance comparisons, and data visualizations that support business decision making across regions, industries and technologies. Follow @IBMIBV on Twitter, and to receive the latest insights by email, visit: www.ibm.com/ibv.

Media Contact
Leslie Park
leslie.park@ibm.com 
201-230-1418

SOURCE IBM

This post was originally published on this site



For enquiries, product placements, sponsorships, and collaborations, connect with us at hello@globalcloudplatforms.com. We'd love to hear from you!


Our humans need coffee too! Your support is highly appreciated, thank you!

Total
0
Shares
Previous Article

IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages

Next Article

Bloomberg Media and Intelligence Squared U.S. present a new limited debate series “That’s Debatable” hosted by Award-Winning Journalist and Moderator John Donvan and featuring AI from IBM Watson

Related Posts

IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages

Joint offering pairs pharmacy supply chain management capabilities with evidence-based drug content, designed to help hospital pharmacy teams manage drug shortages CAMBRIDGE, Mass. and WINSTON-SALEM, N.C., Sept. 1, 2020 /PRNewswire/ -- IBM (NYSE: IBM) Watson Health and OrbitalRX® today announced a strategic collaboration that aims to help address the emerging drug shortage crisis. The companies are combining OrbitalRX's Drug Shortage Management Platform and IBM® Micromedex® into one unified solution called "OrbitalRX and Micromedex," designed to create a single source for healthcare providers and pharmacy teams to access evidence-based treatment information alongside a hospital's current drug inventory status and drug sourcing options. This one solution aims to quickly analyze the supply chain and identify clinical alternatives for drugs that are in short supply. The global drug shortage crisis has accelerated at an alarming rate during the COVID-19 crisis. According to the American Society of Health-Systems Pharmacists (ASHP), close to 200 drugs are currently on the drug shortage list in the U.S. alone. Management of these shortages is further complicated by the fact that shortages vary by drug and location, as noted by the American Medical Association (AMA). The new solution, OrbitalRX and Micromedex, will be designed to evaluate important drug information, clinical evidence, and comparative efficacy, alongside the hospital's drug inventory, purchase history, and utilization data, enabling hospital providers, pharmacists and pharmacy technicians to proactively manage drug shortages. "As hospitals around the world experience shortages of life-saving therapies, there is an immediate, critical need for evidence-based information around clinical alternatives," said Todd Nolen, General Manager, IBM Micromedex Solutions, IBM Watson Health. "We are addressing this critical need by combining our Micromedex content with powerful insights from the OrbitalRX platform. Our goal is to deliver a trusted platform to help pharmacists and other healthcare providers streamline workflow and rapidly respond to drug shortages with appropriate, safe and effective alternative therapies." IBM Micromedex is one of the largest online reference databases for medication information. It is used by more than 4,500 hospitals and health systems worldwide to help support decision-making in medication therapy management, disease and condition management, toxicology, alternative medicine and patient education. OrbitalRX is the only platform designed by hospital pharmacists, for hospital pharmacists, to unify supply chain and clinical utilization to manage drug shortages and deliver the power of real-time situational awareness in hospital pharmacy workflows. "Patient safety can be compromised by supply chain interruptions, limited drug access due to high medication costs, and unforeseen events like COVID-19. OrbitalRX and Micromedex aim to help health system pharmacy departments mitigate these workflow challenges by identifying drug alternatives from a clinical and supplier perspective," said OrbitalRX co-founder and CEO, Adam Orsborn, PharmD, MS. "Rooted in cloud-based technology and evidence-based insights, this new, unified solution is designed to deliver workflow efficiencies that will empower pharmacists and providers to prioritize therapeutic needs."  "Hospital resources are scarcer than ever, especially with drug shortages and supply chain inefficiencies conspiring daily to upend the rigorous efforts of health systems to improve care quality while reducing cost," said OrbitalRX co-founder and Chief Product Officer, Nate Peaty, PharmD, MS. "With these challenges in mind, OrbitalRX and Micromedex plan to provide health systems with a highly intelligent and automated solution designed to help them with one of the most frustrating issues they face today."   OrbitalRX and Micromedex is anticipated to be available in Q4 2020. Please visit www.ibm.com/products/orbitalrx-micromedex.com to learn more about the solution, schedule a live demo, or to register for a webinar on September 24 to learn more. About IBM Watson HealthIBM Watson Health is a data, analytics, and technology partner for the health industry. Supported by the innovation of IBM and intelligence of Watson, we are committed to helping build smarter health ecosystems. Through the combination of our deep industry expertise in health, data and analytics, actionable insights, and reputation for security and trust, Watson Health is working together with its clients and partners to help them achieve simpler processes, better care insights, faster breakthroughs, and improved experiences for people around the world. Learn more at www.ibm.com/watson-health. For more information about IBM visit, www.ibm.com. Statements regarding IBM's future direction and intent are subject to change or withdrawal without notice and represent goals and objectives only.  About OrbitalRX Co-founded by health-system pharmacy leaders, OrbitalRX offers a one-of-a-kind drug shortage management platform which helps to identify risk factors using internal and external data for when a medication shortage could cause harm in your health-system. We offer everything you need to anticipate, evaluate, take action, follow-up, and report in a single, powerful platform designed to improve your overall shortage management strategy. To learn more about how we're changing the way hospital pharmacies monitor their supply and manage shortages in the supply chain, visit www.orbitalrx.com.   IBM Media ContactMatthew Henson917-930-7147matthew.henson@ibm.com OrbitalRX Media Contact  Emily Nichols emily@orbitalrx.com SOURCE IBM Watson Health

Coca-Cola European Partners Signs a Multiyear Agreement with IBM to Accelerate its Strategic Transformation Journey with Hybrid Cloud

- Digital transformation designed to reduce costs and lay foundations for the future- IBM Services to architect industry-specific new platform around IBM hybrid cloud environment LONDON, Aug. 11, 2020 /PRNewswire/ -- Coca-Cola European Partners (CCEP), the world's largest Coca-Cola bottler based on revenue, has signed a multiyear agreement with IBM (NYSE: IBM) to accelerate its transformation to an open hybrid cloud environment using Red Hat OpenShift and Red Hat Enterprise Linux. The move is designed to reduce its operational expenses, increase IT resiliency and leverage analytics and Artificial Intelligence (AI) in its daily operations to bring enhanced business insights and deliver greater service to its millions of customers.   A key priority for CCEP is to streamline its existing IT infrastructure to create a platform for standardised business processes, data and technology. This will create a springboard from which to leverage data analytics, IoT and AI technologies to provide new insights across its operations to help drive further efficiencies. As part of the agreement, IBM Services, with its deep industry expertise, will help CCEP transform to a IBM hybrid cloud environment managed by IBM, including the use of IBM public cloud, and several large SAP workloads. IBM will also provide CCEP with a consolidated view and single point of control over its entire IT infrastructure. Peter Brickley, Chief Information Officer of Coca-Cola European Partners, said: "Our successful collaboration with IBM over the last few years has given us the confidence to take the next step in our strategic cloud-first digital transformation. The selection of IBM's hybrid cloud architecture with Red Hat OpenShift gives us the flexibility to optimize across different public cloud platforms according to our future needs." "As businesses shift to cloud, we understand that each industry and client has unique business needs in their cloud adoption journey. IBM is excited to take Coca-Cola European Partners on this next chapter of their cloud journey delivering on an industry-specific solution as they migrate mission critical workloads to the cloud," said Howard Boville, SVP IBM Cloud. "By selecting IBM for its hybrid cloud environment with decades of industry expertise and experience, CCEP is embarking on a journey towards an open and secure cloud architecture driving greater digital advancement." IBM will help CCEP modernize its IT environment by using Red Hat Enterprise Linux to provide an open standard, cost-effective platform. A cornerstone of this transition will be Red Hat OpenShift, the industry's most comprehensive Kubernetes platform, which will allow CCEP to build mission-critical applications once and run them on IBM public cloud . IBM's Multicloud Management capability will be used to allow the legacy systems, private and public clouds, to be integrated and managed from a single dashboard. IBM and CCEP began their journey to the Cloud in 2018, when IBM successfully moved one third of CCEP's enterprise workloads from a dedicated US data centre to the IBM Cloud in Europe. Red Hat and OpenShift are trademarks or registered trademarks of Red Hat, Inc. or its subsidiaries in the U.S. and other countries. About Coca Cola European Partners For further information visit: www.cocacolaep.com/ About IBM Cloud For further information visit: www.ibm.com/cloud/ CONTACT:Kaveri CamireIBM Communicationskcamire@us.ibm.com SOURCE IBM